Shirley M, Murphy R. Metabolism of LTB4 by isolated hepatocytes: new metabolites and effect of ethanol. Ann NY Acad Sci 1991;629:410–2.
PubMed
Google Scholar
Chauhan K, Bhatt R, Falck J, Capdevila J. Total synthesis of the ethanol inducible, proinflammatory autocoid 3(S)-hydroxy-LTB4 and analogues. Tetrahedron Lett 1994;35:1825–8.
Google Scholar
Shirley M, Reidhead C, Murphy R. Chemotactic LTB4 metabolites produced by hepatocytes in the presence of ethanol. Biochem Biophys Res Comm 1992;185:604–10.
PubMed
Google Scholar
Djuric S, Docter S, Yu S, Tsai B, Anglin C, Gaginella T, et al. Synthesis and pharmacological activity of SC-53228. Bioorgan. Med. Chem. Lett. 1994;4:811–6.
Google Scholar
Fretland D, Anglin C, Bremmer M, Isakson P, Widomski D, Paulson S, Docter S, Djuric S, Penning T, Yu S, McKearn J. Anti-inflammatory effects of the second generation leukotriene B4 receptor antagonist, SC-53228. Inflamm. In press.
Bradley P, Priebat D, Christensen R, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206–9.
PubMed
Google Scholar
Tsai B, Keith R, Villani-Price D, Kachur J, Yang D, Djuric S, et al. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors. J Pharmacol Exp Therap 1994;268:1499–505.
Google Scholar
Djuric S, Fretland D, Penning T. The leukotriene B4 receptor antagonists. Drugs of Future 1992;17:819–30.
Google Scholar